However if IFNAR was blocked after treatment with poly(I:C) alone, there was no detriment to the anti-tumour response, confirming the crucial time-dependent nature of IFN signalling underlying the therapeutic response to ICB (Supplementary Fig. 5d–g). The gene discussed is IFNAR1; the disease is neoplasm.